Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
RRani Therapeutics Holdings Inc. logo
RANINASDAQ

Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc.
Loading price data…
Loading price data…
Chart type
Interval
Moving averages
Up/down colors

Share screenshot

Recent & upcoming events

Aug 13
Earnings 12:11
Q2 earnings
Add to Google Calendar
May 15
Earnings Time TBD
Q1 earnings
Add to Google Calendar
Mar 26
Earnings Time TBD
Full-year earnings
Add to Google Calendar
2025
Nov 6
Earnings Time TBD
Q3 earnings
Add to Google Calendar
Aug 7
Earnings Time TBD
Q2 earnings
Add to Google Calendar
Mar 31
Earnings Time TBD
Full-year earnings
Add to Google Calendar
2024
Nov 14
Earnings Time TBD
Q3 earnings
Add to Google Calendar
May 6
Earnings Time TBD
Q1 earnings
Add to Google Calendar
Mar 20
Earnings Time TBD
Full-year earnings
Add to Google Calendar
2023
Nov 8
Earnings Time TBD
Q3 earnings
Add to Google Calendar
Nov 5
Est.
Earnings 16:10 approx.
Q3 earnings (predicted)
Add to Google Calendar
Dec 31
Est.
Earnings 16:10 approx.
Q3 earnings (predicted)
Add to Google Calendar
2027
May 31
Est.
Shareholder meeting Time TBD
Annual meeting (est.)
Add to Google Calendar

KPI highlights

FY25
Revenue $2M YoY +58.9%
Operating income $-38M margin -2346.0%
Net income $-30M YoY
EPS $-0.45 YoY
P/E
ROE -89.9% Equity ratio 56% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Quarterly fundamentals

Income & cash flow Unit: $1M
Quarter FY24 Q4FY25 Q1FY25 Q2FY25 Q3FY25 Q4FY26 Q1
Revenue 1.030.170.000.001.461.71
Operating income -11.2-12.0-10.5-7.26-8.54-8.34
Net income -15.7-12.7-11.2-7.91-9.07-8.02
Operating CF -11.6-8.52-6.60-4.76-10.8-6.93

F-Score (Piotroski)

4/9 2 of 9 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

Positive ROA ROA -50.6%
Positive operating cash flow $-19M
ROA improved YoY -81.9% → -50.6%
Operating CF exceeds net income (accrual quality) OCF $-19M / net income $-30M
Equity ratio improved* Substitute for the original “decrease in long-term debt” 5.4% → 56.3%
Current ratio improved 1.50× → 4.21×
No dilution (shares outstanding did not increase) No data
Gross margin improved No data
Asset turnover improved 0.03× → 0.03×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio 56.3%
Current ratio 4.2×
Years of positive operating CF 0 of last 6 yrs
Payout ratio 0%
Latest fiscal year result Loss (net loss $30M)

Performance history

Last 10 years
$0M$1M$1M$2M$3M FY20FY21FY22FY23FY24FY25

Income & assets

Unit: $1M
Item FY20FY21FY22FY23FY24FY25
Revenue 0.462.720.000.001.031.63
Operating income -16.5-51.6-63.5-66.1-53.3-38.3
Ordinary income
Net income -16.7-8.33-30.6-34.0-30.0-29.7
Total assets 79.412410857.936.658.6
Equity -11347.436.912.91.9933.0

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: $1M
Item FY20FY21FY22FY23FY24FY25
EPS $0.00$-0.43$-1.28$-1.33$-1.05$-0.45
ROE 14.7%-17.6%-83.0%-264.0%-1506.9%-89.9%
Operating CF -15.0-32.2-46.5-51.2-35.5-18.7
Investing CF -1.20-0.51-72.429.919.8-7.03
Financing CF 72.777.129.00.2313.640.3
FCF -16.2-32.8-48.1-52.5-35.8-18.8

Source: SEC EDGAR (10-K, etc.) (fetched 2026-07-03) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector

Data provided by Twelve Data